Hartzell H.: The Yew Tree: A Biography of the Species. Hulogosi, 1991, pp 1-319
2.
Schiff P., Horwitz S.: Taxol stabilizes microtubules in mouse fibroblast cells. Proc National Acad Sci USA77: 1561-1565, 1980
3.
Blume E.: Taxol and related anticancer drugs. Bethesda, MD, NCIOffice of Cancer Communications, May 19, 1992
4.
Blume E.: Taxol and related anticancer drugs. National Cancer Institute , Office of Cancer Communications: May 19, 1992
5.
Wiernik P., Schwartz E., Einzig A., et al: Phase I trial of taxol given as a 24-hour infusion every 21 days: Responses observed in metastatic melanoma. J Clin Oncol5:1232-1239, 1987
6.
Rowinsky E., Burke P., Kapp J., et al: Phase I and pharmacokinetic study of taxol in refractory acute leukemia. Cancer Res49:4640-4647, 1989
7.
Monsarrat B. , Mariel E., Cros S., et al: Taxol metabolism: Isolation and identification of three major metabolites of taxol in rat bile. Drug Metab Dispos18:895-901,1990
8.
Markman M., Rowinsky E., Hakes T., et al: Phase I study of taxol administered by the intraperitoneal (IP) route: A GOG trial. Proc Am Soc Clin Oncol10:185, 1991 (abstr)
9.
Flora K., Greene R., Jackson W., et al: NCI investigational drugs: Pharmaceutical data 1990. Bethesda, MD, National Cancer Institute, 1990
10.
Waugh W., Trissel L., Stella V.: Stability, compatibility, and plasticizer extraction of taxol (NSC-125973) injection diluted in infusion solutions and stored in various containers. Am J Hosp Pharm58:1520-1524, 1991
11.
Trissel LA, Bready BB: Turbidimetric assessment of the compatibility of taxol with selected other drugs during simulated Y-site injection. Am J Hosp Pharm49:1716-1719, 1992
